ALC-0315

Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay34337-25 25 mg -

5 - 10 Werktage*

290,00 €
Cay34337-50 50 mg -

5 - 10 Werktage*

492,00 €
Cay34337-100 100 mg -

5 - 10 Werktage*

695,00 €
Cay34337-250 250 mg -

5 - 10 Werktage*

1.319,00 €
Cay34337-1 1 g -

5 - 10 Werktage*

2.221,00 €
 
ALC-0315 is an ionizable cationic lipid (pKa 6.09) that has been used in the generation of lipid... mehr
Produktinformationen "ALC-0315"
ALC-0315 is an ionizable cationic lipid (pKa 6.09) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA, siRNA, and plasmid DNA in vitro and in vivo. LNPs containing ALC-0315 and encapsulating siRNA targeting Factor VII mRNA decrease Factor VII mRNA levels in hepatocytes in mice. Administration of severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA in ALC-0315-containing LNPs induces the production of IgG that binds to the SARS-CoV-2 receptor-binding domain (RBD) in rhesus macaques, with a boost in antigen-specific IgG geometric mean titers (GMT) seven and 14 days after a second dose. LNPs containing ALC-0315 and encapsulating ovalbumin mRNA reduce tumor volume in an ovalbumin-expressing B16/F10 murine melanoma model. Formulations containing ALC-0315 have been used in the development of LNPs for the delivery of mRNA-based vaccines.. ALC-0315 is an ionizable cationic lipid (pKa 6.09) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA, siRNA, and plasmid DNA in vitro and in vivo. LNPs containing ALC-0315 and encapsulating siRNA targeting Factor VII mRNA decrease Factor VII mRNA levels in hepatocytes in mice. Administration of severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA in ALC-0315-containing LNPs induces the production of IgG that binds to the SARS-CoV-2 receptor-binding domain (RBD) in rhesus macaques, with a boost in antigen-specific IgG geometric mean titers (GMT) seven and 14 days after a second dose. LNPs containing ALC-0315 and encapsulating ovalbumin mRNA reduce tumor volume in an ovalbumin-expressing B16/F10 murine melanoma model. Formulations containing ALC-0315 have been used in the development of LNPs for the delivery of mRNA-based vaccines.. SMILES: OCCCCN(CCCCCCOC(C(CCCCCC)CCCCCCCC)=O)CCCCCCOC(C(CCCCCC)CCCCCCCC)=O. InChi Code: InChI=1S/C48H95NO5/c1-5-9-13-17-19-27-37-45(35-25-15-11-7-3)47(51)53-43-33-23-21-29-39-49(41-31-32-42-50)40-30-22-24-34-44-54-48(52)46(36-26-16-12-8-4)38-28-20-18-14-10-6-2/h45-46,50H,5-44H2,1-4H3. InChi Key: QGWBEETXHOVFQS-UHFFFAOYSA-N
Schlagworte: 2-hexyl-decanoic acid, 1,1'-[[(4-hydroxybutyl)imino]di-6,1-hexanediyl] ester
Hersteller: Cayman Chemical
Hersteller-Nr: 34337

Eigenschaften

Anwendung: Ionizable amino lipid, lipid nanoparticle formation
MW: 766.3 D
Formel: C48H95NO5
Reinheit: >98%
Format: Solution

Datenbank Information

CAS : 2036272-55-4| Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Signalwort: Danger
GHS-Piktogramme:
H-Sätze: H225, H315, H319
P-Sätze: P210, P233, P240, P241, P242, P243, P264, P280, P321, P302+P352, P303+P361+P353, P305+P351+P338, P332+P313, P337+P313, P362+P364, P370+P378, P403+P235, P501
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "ALC-0315"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen